Cargando…

Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide. The pathogenesis of this disease is closely associated with obesity and insulin resistance. Ginger can have hypolipidemic and antioxidant effects, and act as an insulinsensitizer. OBJECTI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rahimlou, Mehran, Yari, Zahra, Hekmatdoost, Azita, Alavian, Seyed Moayed, Keshavarz, Seyed Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834197/ https://www.ncbi.nlm.nih.gov/pubmed/27110262 http://dx.doi.org/10.5812/hepatmon.34897

Ejemplares similares

Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial
por: Darabi, Zahra, et al.
Publicado: (2019)

Comparison of cardiometabolic risk factors between obese and non-obese patients with nonalcoholic fatty liver disease
por: Yari, Zahra, et al.
Publicado: (2023)

Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial
por: Daneshi-Maskooni, Milad, et al.
Publicado: (2019)

Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial
por: Rahimlou, Mehran, et al.
Publicado: (2022)

Corrigendum: Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial
por: Rahimlou, Mehran, et al.
Publicado: (2022)

Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial
por: Daneshi-Maskooni, Milad, et al.
Publicado: (2018)

The effects of ginger supplementation on inflammatory, antioxidant, and periodontal parameters in type 2 diabetes mellitus patients with chronic periodontitis under non-surgical periodontal therapy. A double-blind, placebo-controlled trial
por: Zare Javid, Ahmad, et al.
Publicado: (2019)

Effects of Vitamin D Supplementation in Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Jalili, Mahsa, et al.
Publicado: (2019)

Diet Macronutrients Composition in Nonalcoholic Fatty Liver Disease: A Review on the Related Documents
por: Hashemi Kani, Ali, et al.
Publicado: (2014)

Probiotics and Nonalcoholic Fatty liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2013)

Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial
por: Jazayeri-Tehrani, Seyed Ali, et al.
Publicado: (2019)

Do symbiotic and Vitamin E supplementation have favorite effects in nonalcoholic fatty liver disease? A randomized, double-blind, placebo-controlled trial
por: Ekhlasi, Golnaz, et al.
Publicado: (2016)

Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
por: Saadati, Saeede, et al.
Publicado: (2019)

The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial
por: Daneshi-Maskooni, Milad, et al.
Publicado: (2017)

Effects of Pharmacologic Dose of Resveratrol Supplementation on Oxidative/Antioxidative Status Biomarkers in Nonalcoholic Fatty Liver Disease Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Asghari, Somayyeh, et al.
Publicado: (2018)

Effect of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease
por: Shamsoddini, Alireza, et al.
Publicado: (2015)

The effects of ginger supplementation on common gastrointestinal symptoms in patients with relapsing-remitting multiple sclerosis: a double-blind randomized placebo-controlled trial
por: Foshati, Sahar, et al.
Publicado: (2023)

Ginger in gastrointestinal disorders: A systematic review of clinical trials
por: Nikkhah Bodagh, Mehrnaz, et al.
Publicado: (2018)

Effects of alpha lipoic acid supplementation on serum lipid profile in patients with metabolic syndrome: A randomized, double-blind, placebo-controlled clinical trial
por: Ahmadi, Mahbubeh, et al.
Publicado: (2022)

Efficacy of the Synbiotic Supplementation on the Metabolic Factors in Patients with Metabolic Syndrome: A Randomized, Triple-Blind, Placebo-Controlled Trial
por: Rahimi, Fatemeh, et al.
Publicado: (2022)

School Nutrition Program; Prevention of Obesity and Fatty Liver in Children
por: Ardalan, Gelayol, et al.
Publicado: (2014)

Gut microbiota profile in patients with nonalcoholic fatty liver disease and presumed nonalcoholic steatohepatitis
por: Mohammadi, Zahra, et al.
Publicado: (2022)

An Accessible and Pragmatic Experimental Model of Nonalcoholic Fatty Liver Disease
por: Emamat, Hadi, et al.
Publicado: (2016)

Liver Mitochondrial DNA Copy Number and Deletion Levels May Contribute to Nonalcoholic Fatty Liver Disease Susceptibility
por: Kamfar, Sharareh, et al.
Publicado: (2016)

Soy Isoflavones Supplementation for Patients with Irritable Bowel Syndrome: A Randomized Double Blind Clinical Trial
por: Jalili, Mahsa, et al.
Publicado: (2015)

Comments on “The Effects of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease”
por: Cheraghpour, Makan, et al.
Publicado: (2016)

Effects of supplementation with main coffee components including caffeine and/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled, clinical trial
por: Mansour, Asieh, et al.
Publicado: (2021)

Effect of a moderately carbohydrate-restricted diet on liver enzymes, steatosis and fibrosis in normal-weight individuals with non-alcoholic fatty liver disease: study protocol for a parallel randomised controlled clinical trial
por: Dashti, Fatemeh, et al.
Publicado: (2023)

The effect of daily consumption of probiotic yogurt on liver enzymes, steatosis and fibrosis in patients with nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized clinical trial
por: Ebrahimi-Mousavi, Sara, et al.
Publicado: (2022)

Efficacy of Ginger Supplementation in Relieving Persistent Hypothyroid Symptoms in Patients with Controlled Primary Hypothyroidism: A Pilot Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Ashraf, Hamide, et al.
Publicado: (2022)

Effect of Ginger Powder Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial
por: Rafie, Roya, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease and dairy products consumption: Results from FASA Persian cohort study
por: Keshavarz, Zahra, et al.
Publicado: (2022)

Acute Fatty Liver of Pregnancy: A Life-Threatening Condition Requiring a Life-Saving Approach
por: Gorginzadeh, Mansoureh, et al.
Publicado: (2016)

Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease
por: Ahn, Sang Bong, et al.
Publicado: (2019)

Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial
por: Harrison, Stephen A., et al.
Publicado: (2023)

How Much Weight Loss is Effective on Nonalcoholic Fatty Liver Disease?
por: Ghaemi, Alireza, et al.
Publicado: (2013)

Assessment of transient elastography (FibroScan) for diagnosis of fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis
por: Hashemi, Seyed-Abbas, et al.
Publicado: (2016)

The effects of onion consumption on treatment of metabolic, histologic, and inflammatory features of nonalcoholic fatty liver disease
por: Emamat, Hadi, et al.
Publicado: (2016)

A CONSORT-Compliant, Randomized, Double-Blind, Placebo-Controlled Pilot Trial of Purified Anthocyanin in Patients With Nonalcoholic Fatty Liver Disease
por: Zhang, Pei-Wen, et al.
Publicado: (2015)

Evaluation of the Effects of Oral N-Acetylcysteine and a Placebo in Paraclinical and Oxidative Stress Parameters of Patients with Chronic Hepatitis B
por: Shohrati, Majid, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_0klkjkspjq6hb1rvh2f5u5645s